|
시장보고서
상품코드
2008062
클로스트리듐 디피실 진단 시장 : 진단 검사별, 최종사용자별, 지역별Clostridium Difficile Diagnostics Market, By Diagnostic Test, By End User, By Geography |
||||||
클로스트리듐 디피실 진단 시장은 2026년에 11억 1,880만 달러로 추정되며, 2033년까지 18억 5,210만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 7.5%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 11억 1,880만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 7.50% | 2033년 시장 규모 예측: | 18억 5,210만 달러 |
클로스트리듐 디피실 감염증(CDI)은 기존의 임상 검사법을 통해 진단되지만, 시간과 비용을 크게 절감할 수 있는 신속한 현장 진단 검사도 가능합니다. 클로스트리듐 디피실 감염은 세균에 의해 발생하는 질병입니다. 이 질환은 설사, 메스꺼움, 대장 염증 등 다양한 증상으로 나타납니다. 또한 항생제는 체내 유익균을 죽이고 클로스트리디움 디피실균의 증식을 촉진하기 때문에 자주 복용하면 클로스트리디움 디피실균 감염의 원인이 되기도 합니다. 수양성 설사, 탈수, 발열, 메스꺼움, 식욕부진, 체중감소는 클로스트리듐 디피실 감염의 전형적인 증상입니다. CDI 검출에 사용되는 진단 검사로는 독소 A/B에 대한 효소면역측정법(EIA)이 있습니다. 그러나 민감도가 낮기 때문에 더 이상 단독 1차 검사로 간주되지 않습니다. 기타 검사로는 글루타메이트 탈수소효소 효소 면역측정법, 중합효소 연쇄 반응(PCR)에 기반한 분자검사 등이 있습니다. 또한, 등온증폭 기술도 CDI 진단법으로 미국 식품의약국(FDA)의 승인을 받았습니다. Cepheid, BD Diagnostics, DiaSorin, Inc, Abbott Laboratories, Thermo Fisher Diagnostics, Luminex Corporation 등의 제조업체는 클로스트리듐 디피실 감염을 위한 고급 진단 검사를 제공하고 있습니다. 예를 들어, Cepheid의 GeneXpert 검사나 Luminex Corporation의 Nanosphere Verigene SP는 클로스트리듐 디피실 감염에 대해 높은 민감도와 빠른 결과를 제공합니다.
시장 역학
클로스트리듐 디피실 감염증의 유병률 증가, 실시간 중합효소 연쇄 반응(RT-PCR)과 같은 정확하고 진보된 진단 기술의 가용성, 메트로니다졸과 같은 표준 항생제의 제네릭 의약품의 존재와 같은 요인으로 인해 예측 기간 동안 클로스트리듐 디피실 진단 및 치료 시장의 성장을 촉진할 것으로 예상됩니다. 또한, 다양한 기관과 제조업체들이 클로스트리듐 디피실 감염과 그 심각성에 대한 인식을 높이기 위해 노력하고 있습니다. 예를 들어, 2018년 3월, C Diff 재단은 인식 개선과 치료 옵션 확대에 기여한 공로를 인정하여 제약회사 CutisPharma, Inc.에 'Making a Difference' 상을 수여했습니다.
본 조사의 주요 특징.
- 이 보고서는 세계 클로스트리디움 디피실 진단 시장에 대한 상세한 분석을 제공하며, 2025년을 기준 연도로 하여 예측 기간(2026-2033년)의 시장 규모와 CAGR(%)을 제시합니다.
- 이 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 이 보고서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들의 경쟁 전략에 대한 중요한 인사이트도 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 클로스트리듐 디피실 진단 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 금융 분석가1 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 클로스트리듐 디피실 진단 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 클로스트리듐 디피실 진단 시장 : 진단 검사별, 2020-2033년
제5장 세계의 클로스트리듐 디피실 진단 시장 : 최종사용자별, 2020-2033년
제6장 세계의 클로스트리듐 디피실 진단 시장 : 지역별, 2020-2033년
제7장 경쟁 구도
제8장 섹션
KSMClostridium Difficile Diagnostics Market is estimated to be valued at USD 1,118.8 Mn in 2026 and is expected to reach USD 1,852.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,118.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.50% | 2033 Value Projection: | USD 1,852.1 Mn |
Clostridium difficile infection (CDI) is diagnosed with the help of conventional laboratory testing methods, however, rapid point-of-care diagnostic tests are also available, which can save time and costs significantly. Clostridium difficile is a disease caused by bacteria. The illness manifests as a variety of symptoms, such as diarrhea, nausea, and colon inflammation. Furthermore, since antibiotics kill healthy bacteria in the body and promote the growth of C. difficile bacteria, they are also responsible for clostridium difficile infection when taken frequently. Watery diarrhoea, dehydration, fever, nausea, loss of appetite, and weight loss are typical signs of clostridium difficile infection. Diagnostic assays used for detection of CDI include enzyme immunoassays (EIAs) for toxins A/B. However, these are no longer considered stand-alone primary tests due to poor sensitivity. Other tests include glutamate dehydrogenase enzyme immunoassay and molecular assay based on polymerase chain reaction. Isothermal amplification technology has also been approved by the U.S. Food & Drug Administration for diagnosis of CDI. Manufacturers such as Cepheid, BD Diagnostics, DiaSorin, Inc., Abbott Laboratories, Thermo Fisher Diagnostics, and Luminex Corporation offer advanced diagnostic tests for clostridium difficile infection. For instance, Cepheid GeneXpert test, Nanosphere Verigene SP by Luminex Corporation offer sensitivity and timely results for clostridium difficile infection.
Market Dynamics
Factors such as rising prevalence of clostridium difficile infection, availability of precise and advanced diagnostic techniques such as real time-polymerase chain reaction (RT-PCR), and presence of generic versions of standard antibiotics such as metronidazole is expected to boost growth of the clostridium difficile diagnostics and treatment market over the forecast period. Furthermore, various organizations and manufacturers are working towards increasing awareness about clostridium difficile infection and its severity. For instance, in March 2018, C Diff Foundation awarded its "Making a Difference" award to CutisPharma, Inc.-a pharmaceutical company, for contribution of the company towards increasing awareness and expanding treatment options.
Key features of the study
- This report provides an in-depth analysis of the global clostridium difficile diagnostics market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global clostridium difficile diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals, Inc., Abbott Laboratories, Trinity Biotech Plc., Summit Therapeutics, Sanofi S.A., Novartis AG, and AstraZeneca Plc
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global Clostridium Difficile Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Clostridium Difficile Diagnostics market
Clostridium Difficile Diagnostics Market Segmentation
- By Diagnostic Test (Revenue, USD Mn, 2020 - 2033)
- Enzyme Immunoassays
- Real-Time Polymerase Chain Reaction (RT-PCR)
- Nucleic Amplification Tests (NAAT)
- Stool Test
- GDH Antigen Test
- Toxin A and B Test
- Blood Test
- Colonoscopy or Sigmoidoscopy
- Others
- By End User Insights (Revenue, USD Mn, 2020 - 2033)
- Hospitals
- Diagnostic Centers
- Specialty Clinics
- Others
- By Region Insights (Revenue, USD Mn, 2020 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Hoffmann-La Roche Ltd,
- Thermo Fisher Scientific
- Merck & Co., Inc.
- Pfizer, Inc.
- Actelion Pharmaceuticals, Inc.
- Abbott Laboratories
- Trinity Biotech Plc.
- Summit Therapeutics
- Sanofi S.A.
- Novartis AG
- AstraZeneca Plc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Diagnostic Test
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Recent Product Approvals/Launch
- Epidemiology
- Market Trends
- Porter's Analysis
- PEST Analysis
- Technology Advancement
- Regulatory Scenario
4. Global Clostridium Difficile Diagnostics Market, By Diagnostic Test, 2020-2033, (USD Mn)
- Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2020-2033
- Segment Trends
- Enzyme Immunoassays
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- Real-Time Polymerase Chain Reaction (RT-PCR)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- Nucleic Amplification Tests (NAAT)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- Stool Test
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- GDH Antigen Test
- Toxin A and B Test
- Blood Test
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- Colonoscopy or Sigmoidoscopy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
5. Global Clostridium Difficile Diagnostics Market, By End User, 2020-2033, (USD Mn)
- Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2020-2033
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- Diagnostic Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
6. Global Clostridium Difficile Diagnostics Market, By Region, 2020-2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2033, (USD Mn)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Actelion Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Trinity Biotech Plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Summit Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca Plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
8. Section
- Research Methodology
- About Us
(주말 및 공휴일 제외)
